Search - tctmd.com

Displaying 21 - 40 of 41

Sort: Relevancy | Date

Presentation TCT 2025

Predictors of a Positive Treadmill Stress Test in Patients with Asymptomatic Severe Aortic Stenosis: Insights from the EARLY TAVR Treadmill Registry

Presenter: Philippe Genereux

October 25, 2025

Presentation TCT 2025

Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Women with Severe Aortic Stenosis: The RHEIA Trial

Presenter: Philippe Pibarot

October 25, 2025

Presentation TCT 2025

Thirty-Day and One-Year Outcomes of the Navitor TAVR System in Patients with Low or Intermediate Risk

Presenter: Stephen Grant Worthley

October 25, 2025

Presentation TCT 2025

Valve Performance of Self-Expanding vs. Balloon-Expandable TAVR in Patients with a Small Aortic Annulus: Five-Year Results From the OCEAN-TAVI Registry

Presenter: Fumiaki Yashima

October 25, 2025

Presentation TCT 2025

Early Outcomes of Redo-TAVI With SAPIEN Platform in a Real-World Prospective Cohort: The ReTAVI Registry

Presenter: Giuseppe Tarantini

October 25, 2025

News Daily News

US Stroke Rehab System Not Serving Patient Needs, Societies Say

L.A. McKeown

August 07, 2025

News Daily News

SCAI/HRS Issue First Practice Guideline for LAAO

Yael L. Maxwell

August 06, 2025

News Daily News

People With Tricuspid Valve Disease Want More Information, Sooner

Yael L. Maxwell

July 17, 2025

Presentation Interventional Complications 2025

I Am in Trouble (Hospital, Partners and/or Medical Staff)

Presenter: Cynthia Rutzick

July 11, 2025

Presentation NY Valves 2025

SAVR vs. TAVR Strategy Trials (PARTNER 3 and RHEIA)

Presenter: Didier Tchetche

June 27, 2025

Presentation NY Valves 2025

30-Day Outcomes of the Lux-Plus TTVR System in Large Tricuspid Annuli in the TRINITY Trial

Presenter: Thomas Elie Modine

June 25, 2025

Presentation NY Valves 2025

SIEGEL TAVR: FIH 1 year & US Early Feasibility 30 Day Results

Presenter: Pradeep K. Yadav

June 25, 2025

Presentation NY Valves 2025

PRO – SURGERY: 3 Reasons Why Surgery Is the Best Option for This Patient

Presenter: Christine J. Chung

June 25, 2025

Presentation NY Valves 2025

PRO – TAVR: 3 Reasons Why TAVR Is the Best Option for This Patient

Presenter: Isaac George

June 25, 2025

News Conference News EuroPCR 2025

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Michael O'Riordan

May 23, 2025

News Daily News

Conversion Therapy Tied to Worse CV Risk Factors in Sexual, Gender Minorities

Caitlin E. Cox

May 08, 2025

News Conference News SCAI 2025

More Patient-Prosthesis Mismatch With TAVI in Women, but 5-Year Survival Unaffected

L.A. McKeown

May 02, 2025

News Conference News ACC 2025

Cardiologists Plot Next Moves After New Board Rejected

Yael L. Maxwell

April 11, 2025

News Industry News

Pi-Cardia Reports First Commercial Cases with ShortCut™

March 03, 2025

News Conference News STS 2025

Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival

Yael L. Maxwell

January 27, 2025

Advertisement

Predictors of a Positive Treadmill Stress Test in Patients with Asymptomatic Severe Aortic Stenosis: Insights from the EARLY TAVR Treadmill Registry

Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Women with Severe Aortic Stenosis: The RHEIA Trial

Thirty-Day and One-Year Outcomes of the Navitor TAVR System in Patients with Low or Intermediate Risk

Valve Performance of Self-Expanding vs. Balloon-Expandable TAVR in Patients with a Small Aortic Annulus: Five-Year Results From the OCEAN-TAVI Registry

Early Outcomes of Redo-TAVI With SAPIEN Platform in a Real-World Prospective Cohort: The ReTAVI Registry

US Stroke Rehab System Not Serving Patient Needs, Societies Say

SCAI/HRS Issue First Practice Guideline for LAAO

People With Tricuspid Valve Disease Want More Information, Sooner

I Am in Trouble (Hospital, Partners and/or Medical Staff)

SAVR vs. TAVR Strategy Trials (PARTNER 3 and RHEIA)

30-Day Outcomes of the Lux-Plus TTVR System in Large Tricuspid Annuli in the TRINITY Trial

SIEGEL TAVR: FIH 1 year & US Early Feasibility 30 Day Results

PRO – SURGERY: 3 Reasons Why Surgery Is the Best Option for This Patient

PRO – TAVR: 3 Reasons Why TAVR Is the Best Option for This Patient

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Conversion Therapy Tied to Worse CV Risk Factors in Sexual, Gender Minorities

More Patient-Prosthesis Mismatch With TAVI in Women, but 5-Year Survival Unaffected

Cardiologists Plot Next Moves After New Board Rejected

Pi-Cardia Reports First Commercial Cases with ShortCut™

Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content